Medicinal Product and Medicinal Product Forms

When a clinical drug is created, the following supertypes must either already exist or must be created:

Medicinal Product containing onlyMedicinal Product containingMedicinal Product Form (MPF)

For example,

1172863005 Paracetamol 1 g oral tablet has the following supertypes:

These concepts in the International Release, their descriptions, and their| Has active ingredient (attribute)|value, represent the base ingredient, not a modification.

For example,

1204319004 |Product containing precisely retinol (as retinol palmitate) 50000 unit/1 milliliter conventional release solution for injection (clinical drug)| has medicinal product and medicinal product form supertypes with retinol , not retinol palmitate. Retinol palmitate is a modification of Retinol and thus should not be used in the creation of the medicinal product and medicinal product form supertypes.

Exceptions to use a modified substance are explicitly identified below:

Exceptions
Elucidation
Examples

Benzylpenicillin

When the active ingredient has an Is modification of (attribute) value of 323389000 |Benzylpenicillin (substance)|.

1234765004

Chemical element compound with multiple modification

Instances where the chemical element compound has two or more Is Modification of (attribute)s

422232005

Chloral hydrate

273948005 |Chloral hydrate (substance)| is a modification of Chloral. However, chloral is unstable on its own and always exists in the hydrated form.

778711000

Liposome or lipid complex substances

< 414612001

Liposomal agent (substance)

These subtypes have some sort of modification, but they can be used to create:

  • Product containing only x (medicinal product)

  • Product containing only x in y dose form (medicinal product form)

Do not use to create:

  • Product containing x (medicinal product)

  • Product containing x in y dose form (medicinal product form)

Pegylated substance

There is no technical way to identify these concepts, though they will often begin with peg-.

385544005

Radiopharmaceutical

< 89457008 Radioactive isotope (substance)|

783865003

Silver sulfadiazine

387112002 |Silver sulfadiazine (substance)| is a modification of 74523009 |Sulfadiazine (substance)|.

864009007

Sodium valproate

387481005 |Sodium valproate (substance)| is a modification of 387080000 |Valproic acid (substance)|.

766519009

Provide Feedback

Last updated